HPV73 a nonvaccine type causes cervical cancer

HPV73 is classified as possibly oncogenic. It is neither routinely evaluated in HPV screening, nor covered by any of the prophylactic vaccines. We sought to investigate the carcinogenic characteristics of HPV73. Molecular studies were performed on eight cervix cancer biopsy specimens containing HPV73 from a cross‐sectional cancer cohort of 590 women referred to the National Cancer Institute in Rio de Janeiro, Brazil. Transcriptional activity of HPV73 was evaluated by detection of spliced transcripts of E6/E6* and E1^E4 in cDNA created from RNA isolated from fresh tissue. Disruption of viral E1 and E2 genes in the tumor DNA was assessed by overlapping PCR amplification. Evaluation of viral integration was performed using a customized capture panel and next‐generation sequencing, and an in‐house bioinformatic pipeline. HPV73 E6/E6* transcripts were found in 7/7 specimens with available RNA, and three also had HPV73 E1^E4 transcripts. Disruption of E1 and E2 genes was observed in 4/8 specimens. Integration of HPV73 sequences into the cancer cell genomes was identified in all cervix cancer tissues. These results provide evidence that HPV73 is an oncogenic virus that can cause invasive cervix cancer. With current molecular screening and HPV vaccination, not all cervix cancers will be prevented.

[1]  R. DeSalle,et al.  Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61). , 2018, Virology.

[2]  T. Iftner,et al.  Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers , 2017, Papillomavirus research.

[3]  M. Szklo,et al.  Human Papillomavirus Genotype Distribution among Cervical Cancer Patients prior to Brazilian National HPV Immunization Program , 2017, Journal of environmental and public health.

[4]  Nicolas Wentzensen,et al.  Carcinogenic human papillomavirus infection , 2016, Nature Reviews Disease Primers.

[5]  M. Soares,et al.  Identification of novel human papillomavirus lineages and sublineages in HIV/HPV-coinfected pregnant women by next-generation sequencing. , 2016, Virology.

[6]  J. T. Cox,et al.  Evaluating HPV‐negative CIN2+ in the ATHENA trial , 2016, International journal of cancer.

[7]  Yang Ke,et al.  Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology , 2015, Oncotarget.

[8]  Thomas D. Wu,et al.  A comprehensive transcriptional portrait of human cancer cell lines , 2014, Nature Biotechnology.

[9]  N. Grabe,et al.  Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer , 2014, The Journal of pathology.

[10]  T. Ried,et al.  Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability , 2014, Genome research.

[11]  C. Sung,et al.  Prevalence, distribution, and viral burden of all 15 high-risk human papillomavirus types in adenosquamous carcinoma of the uterine cervix: a multiplex real-time polymerase chain reaction-based study. , 2014, Human pathology.

[12]  Jay Shendure,et al.  The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line , 2013, Nature.

[13]  Vivek Gopalan,et al.  The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis , 2012, Nucleic Acids Res..

[14]  M. Schiffman,et al.  Comparison of the cobas Human Papillomavirus (HPV) Test with the Hybrid Capture 2 and Linear Array HPV DNA Tests , 2011, Journal of Clinical Microbiology.

[15]  K. Pummer,et al.  Penile Carcinogenesis in a Low-Incidence Area: A Clinicopathologic and Molecular Analysis of 115 Invasive Carcinomas With Special Emphasis on Chronic Inflammatory Skin Diseases , 2011, The American journal of surgical pathology.

[16]  Christopher J. Miller,et al.  Digital squamous cell carcinoma and association with diverse high-risk human papillomavirus types. , 2011, Journal of the American Academy of Dermatology.

[17]  S. Franceschi,et al.  Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication , 2011, International journal of cancer.

[18]  R. Burk,et al.  Degradation of p53 by Human Alphapapillomavirus E6 Proteins Shows a Stronger Correlation with Phylogeny than Oncogenicity , 2010, PloS one.

[19]  C. Schanbacher,et al.  Human papillomavirus type 73 in primary and recurrent periungual squamous cell carcinoma. , 2008, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[20]  J. Doorbar,et al.  Molecular biology of human papillomavirus infection and cervical cancer. , 2006, Clinical science.

[21]  R. DeSalle,et al.  The carcinogenicity of human papillomavirus types reflects viral evolution. , 2005, Virology.

[22]  H. Cubie,et al.  Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population , 2003, Journal of clinical pathology.

[23]  E. Stockfleth,et al.  Distribution of HPV 53, HPV 73 and CP8304 in genital epithelial lesions with different grades of dysplasia , 2001, International Journal of Gynecologic Cancer.

[24]  F. Wiklund,et al.  Seroepidemiology of human papillomavirus type 73: A sexually transmitted low‐risk virus , 2000, International journal of cancer.

[25]  R. Burk,et al.  Natural history of cervicovaginal papillomavirus infection in young women , 1998 .

[26]  A. Mincheva,et al.  Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization , 1987, Medical Microbiology and Immunology.

[27]  S. O’Brien,et al.  Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa. , 1987, Virology.

[28]  F. Sitas.  IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (incl Sitas F.) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens , 2011 .

[29]  Terrence S. Furey,et al.  The UCSC Genome Browser Database , 2003, Nucleic Acids Res..